ArticleScience China. Life sciences2024

Turning point of organoid transplantation: first-in-human trial of iPSC-derived retinal organoid grafting in patients with retinitis pigmentosa.

Chang-Jun Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.